https://www.selleckchem.com/products/rk-33.html
Pharmacogenetic effects of statins on clinical changes in Alzheimer's disease (AD) could be mediated by epistatic interactions among relevant genetic variants involved in cholesterol metabolism. To investigate associations of HMGCR (rs3846662), NR1H2 (rs2695121), or CETP (rs5882rs708272) with cognitive and functional changes in AD, with stratification according to APOEɛ4 carrier status and lipid-lowering treatment with lipophilic statins. Consecutive outpatients with late-onset AD were screened with cognitive tests, while caregivers
Like
Comment
Share
